1,078 results found

On 12 July 2018 the UK Government published its long-awaited White Paper on "The Future Relationship between the United Kingdom and the European Union", which, according to the foreword ...

The Court of Justice of the European Union yesterday issued its judgment in relation to Swiss chocolate giant Nestlé's EU trade mark for the shape of its KitKat chocolate bar.

Based on the increasing recognition of the role of food and nutrition in health, the current "food as medicine" movement encompasses a range of food-based interventions for the prevention...

The UK Government has today formally adopted the Windsor Framework agreed with the European Commission after a major element, the Stormont Brake, won the support of the majority of MPs.

CBD falls under novel foods regulation in Great Britain as it was not consumed to a significant degree in the EU before 15 May 1997, requiring pre-market authorisation from...

LONDON (11 November 2025) – Global consulting firm, AlixPartners, today released its 2025 UK Retail Christmas Sales Forecast, projecting that clothing sales are likely to deliver the strongest year-on-year...

A major reform of competition and consumer protection law is coming soon to the UK. The long-awaited Digital Markets, Competition and Consumers Bill will make major...

The Soup Kitchen in London is a shining example of how community organisations can make a real difference in the lives of those who are struggling.

On 18 January, a new statutory instrument, the Human Medicines (Amendment) Regulations 2019 (the Amending Regulations), which amend the Human Medicines Regulations 2012, was laid before Parliament.

The UK's Advertising Standards Authority has issued groundbreaking rulings on weight-loss medicine advertising, including its first decisions on oral GLP-1 treatments. These cases establish critical boundaries for pharmaceutical advertisers, demonstrating that avoiding product names or images won't necessarily shield companies from regulatory action when promoting prescription-only medicines.

In a recent case concerning the Pharmaceutical Price Regulation Scheme (PPRS) the Court has upheld Glaxosmithkline’s (GSK) contention that it was not prohibited from including volumes of sales from branded products sold to fulfil generic prescriptions in its calculation of the list price reduction that it has delivered under the PPRS.

As a regulatory lawyer long-steeped in the world of stem cells and regenerative medicine, I'm bound to latch onto the title of a recent Nature piece with particular interest.

The recent theft of 22 tonnes of premium cheddar underscores rising food crime in the UK, prompting food businesses to reassess supply chain integrity and compliance with food safety regulations.

Drug offences in the UK can have serious consequences, especially when they involve Class A or Class B substances. Convictions for drug-related offences depend on the type of drug involved.

The UK Government's recent decision, in consultation with the devolved administrations, to close down all "non-essential premises" will have considerable impact on the licensed trade in Scotland.

Recently a patient died after suffering from an allergic reaction to Chlorhexidine. David Reissner discusses this issue and provides some recommendations.

The Food and Drug Administration has announced the availability of a new draft guidance document entitled "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices."